GLP-1s: 8 things hospital leaders should know
Here are eight things health system and hospital leaders should know about these medications: 1. What does “GLP-1” mean? The acronym stands for glucagon-like peptide-1 receptor agonist. The gut hormone prompts insulin secretion, suppresses appetite and promotes a feeling of fullness. GLP-1 drugs mimic these physiological effects. 2. Which medications are approved? As of May […]
Protein Drinks Keep Punching, As Core Brands Grow and Occasions Expand
The protein-in-everything trend has flared up at times over the past decade, but current conditions — with tailwinds from health and wellness now supercharged by the arrival of Ozempic and GLP-1 drugs — only seem to be growing more favorable.
Fracture Risk May Vary Between Weight-Loss Methods
(MedPage Today) — ORLANDO — Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score matched data suggested. Among 2,887 matched pairs, adults with obesity who received the GLP-1 receptor…
Barron’s: Novo Nordisk Says CEO to Step Down
From Barron’s Novo Nordisk _ CEO Lars Fruergaard Jørgensen will step down as CEO of the Danish maker of GLP-1 drugs Ozempic and Wegovy. It was a “mutual agreement,” Novo said in a statement Friday. The search for Fruergaard Jørgensen’s successor is ongoing, the company added. Novo Nordisk stock was up about 1.8% in Denmark. […]
“Ozempic Tongue” Is The Latest “Nasty” Side Effect Of Weight-Loss Meds, As More Celebs Speak Out
A growing number of users say Ozempic is rewiring their taste buds in ways they never saw coming. The blockbuster weight loss drug isn’t just shrinking waistlines. It’s changing how people experience food altogether, leading to the phenomenon that’s now being called the Ozempic tongue. It takes away “all the joy of eating away,” one said […]
Who deserves weight-loss drugs? | David A Kessler
The struggle to obtain these medications illustrates the dangerous mess the US healthcare system has become, writes the former FDA chief The American healthcare system is broken. It is too complicated and too hard for people to get the care and medications they need. More than 70% of Americans feel it has failed them. The […]
The Beachbody Company, Inc. (NYSE:BODI) Q1 2025 Earnings Call Transcript
The Beachbody Company, Inc. (NYSE:BODI) Q1 2025 Earnings Call Transcript May 14, 2025 Operator: Good afternoon. Thank you for attending today’s Beachbody Company, Inc. First Quarter 2025 Earnings Conference Call. My name is Victoria and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call […]
Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective treatments for type 2 diabetes (T2DM), obesity, and cardiovascular disease.1–3 Beyond these indications, they have shown promising clinical efficacy in conditions such as chronic kidney disease, metabolic dysfunction–associated steatohepatitis, obstructive sleep apnea, and Parkinson’s disease.4–6 With proven efficacy and increasing global use, there is a growing need […]
Weekly Dose of Optimism #144
Hi friends 👋, Happy Friday and welcome back to our 144th Weekly Dose of Optimism. We got baby-saving treatments, a new class of Ozempic-level-impressive drugs, two of the world’s largest companies open sourcing AI science tools, alchemy (sort of), and the first good news in overdoses I’ve read in…forever? These are the types of weeks […]
STAT+: Pharmalittle: We’re reading about Novo Nordisk CEO stepping down, hospitals making drugs, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, for the most part, is rather modest. We plan to catch up on our reading, promenade with the official mascots, hang out at […]